Estradiol furoate
 | |
| Clinical data | |
|---|---|
| Trade names | Di-Folliculine |
| Other names | EF; 17-Furoylestradiol; 17-(2-Furancarbonyl)estradiol |
| Routes of administration | Intramuscular injection |
| Drug class | Estrogen; Estrogen ester |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C23H26O4 |
| Molar mass | 366.457 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Estradiol furoate (EF), or estradiol 17β-furoate, sold under the brand name Di-Folliculine, is an estrogen medication and estrogen ester which is no longer marketed.[1] It is the C17β furoate ester of estradiol.[1] Estradiol benzoate has also been marketed under the brand name Di-Folliculine, and should not be confused with estradiol furoate.[2]
The duration of action of the related estradiol ester estradiol 3-furoate by intramuscular injection was studied in women in 1952.[3] Its duration in oil solution was found to be similar to that of estradiol benzoate in oil solution and shorter than that of estradiol dipropionate in oil solution.[3]
See also
References
- ^ a b Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. p. 898. ISBN 978-1-4757-2085-3.
- ^ Pharmaceutical Abstracts. American Pharmaceutical Association. 1941. p. 149.
- ^ a b Ferin J (January 1952). "Relative duration of action of natural and synthetic estrogens administered parenterally in women with estrogen deficiency". The Journal of Clinical Endocrinology and Metabolism. 12 (1): 28–35. doi:10.1210/jcem-12-1-28. PMID 14907837.